Tabrix Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Angel

  • Investors
  • 5

Tabrix General Information

Description

Developer of novel drugs intended to fight difficult-to-treat infections. The company focuses on the treatment of drug-resistant tuberculosis, which reduces multidrug-resistant infections, increases the efficacy of current antibiotics, and reduces treatment time and relapse, enabling patients to fight against pulmonary infections.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • CtF, 46 Grafton Street
  • Manchester M13 9NT
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • CtF, 46 Grafton Street
  • Manchester M13 9NT
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tabrix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Angel (individual) 02-Mar-2023 Completed Generating Revenue
4. Accelerator/Incubator 06-Jan-2023 Completed Generating Revenue
3. Accelerator/Incubator 01-May-2022 Completed Generating Revenue
2. Accelerator/Incubator 28-Mar-2022 $32.3K $32.3K Completed Generating Revenue
1. University Spin-Out 01-Jan-2021 Completed Generating Revenue
To view Tabrix’s complete valuation and funding history, request access »

Tabrix Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
European Fund for Regional Development Corporation
INCATE Accelerator/Incubator
Health Innovation Manchester Corporation
The University of Manchester University
To view Tabrix’s complete investors history, request access »

Tabrix FAQs

  • When was Tabrix founded?

    Tabrix was founded in 2021.

  • Where is Tabrix headquartered?

    Tabrix is headquartered in Manchester, United Kingdom.

  • What industry is Tabrix in?

    Tabrix’s primary industry is Drug Discovery.

  • Is Tabrix a private or public company?

    Tabrix is a Private company.

  • What is Tabrix’s current revenue?

    The current revenue for Tabrix is .

  • How much funding has Tabrix raised over time?

    Tabrix has raised $59.4K.

  • Who are Tabrix’s investors?

    , European Fund for Regional Development, INCATE, Health Innovation Manchester, and The University of Manchester have invested in Tabrix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process